Explore the way our Real-World Data fuels research breakthroughs
Speak to our teamDeriving accurate and unbiased insights from real world data, particularly from claims data, can be challenging. Without careful consideration and a deep understanding of the common pitfalls associated with real world data, analysis results can be prone to bias and errors.
Clarivate experts go through great lengths to identify key strategies to address these challenges, leveraging broad ecosystem of data assets, advanced analytics, and human expertise.
Discover how our data analysis strategies effectively bridge data gaps
Our focus goes beyond data collection – we’re empowering transformative research and insights that shape the future of life sciences industry. Our commitment to data quality and rigorous analysis shines through the numerous peer-reviewed publications that have harnessed our Real-World Data as a foundational methodology of their studies.
With an expanding catalog of over 30 peer-reviewed publications, our Real-World Data stands as a dependable asset for researchers and authorities worldwide. Recognizing the indispensable role of data quality in impactful research and evidence generation, we consistently go the extra mile to identify and address gaps in our data to ensure the integrity and interpretability of analytics results.
Company engaged in research | Research Paper Title | Publication Journal | Publication Date | Publication link |
Alexion | Prevalence of NF1 in the US: A claims based analysis | Global NF conference | Jun 20, 2024 | Click here |
Nestle | Healthcare resource utilization and costs associated with a peptide-based enteral formula with fruit and vegetable ingredients: retrospective analysis of children and adults in post-acute care | Value in Health | Jun 01, 2024 | Click here |
Nestle | Gastrointestinal intolerance and healthcare resource utilization in children with motility disorders receiving a whey peptide-based enteral formula in post-acute care: a retrospective analysis | Gastroenterology | May 18, 2024 | Click here |
Alexion | Prevalence And Incidence Of Attr Amyloidosis In The United States: Insights From Claims Database And Electronic Health Records | North American Society for Pediatric Gastroenterology, Hepatology and Nutrition | Apr 08, 2024 | Click here |
Nestle | Enhanced gastrointestinal tolerance in adults receiving a plant-based peptide enteral formula in post-acute care: a retrospective analysis | Journal of Parenteral and Enteral Nutrition | Mar 02, 2024 | Click here |
Nestle | Clinical and health economic benefits associated with the use of peptide-based enteral formulas in pediatric patients with short bowel syndrome | Journal of Parenteral and Enteral Nutrition | Feb 18, 2024 | Click here |
Nestle | Reduced cost of care associated with switching hypoallergenic amino acid-based formulas during 2022 US nationwide formula shortage | Journal of Allergy and Clinical Immunology | Feb 01, 2024 | Click here |
Alexion | Incidence and prevalence of myasthenia gravis in the US – a claims based study | Journal of Neurology | Dec 01, 2023 | Click here |
Nestle | Transition of hypoallergenic amino acid formulas during the infant formula shortage: impact on clinical outcomes | Journal of Pediatric Gastroenterology and Nutrition | Oct 04, 2023 | Click here |
Nestle | 2022 US infant formula recall: The health economic impact of switching hypoallergenic amino acid formulas in children | Journal of Pediatric Gastroenterology and Nutrition | Oct 04, 2023 | Click here |
Nestle | Gastrointestinal tolerance of a peptide-based enteral formula with fruit and vegetable ingredients: retrospective analysis of children in post-acute care | Journal of Pediatric Gastroenterology and Nutrition | Oct 04, 2023 | Click here |
Johnson & Johnson (Janssen) | Utilization and cost of molecular diagnostics and genetic testing prescribed by various medical specialties in the United States | Value in Health | May 01, 2023 | Click here |
Johnson & Johnson (Janssen) | Real-world data analysis of genetic testing for inherited retinal diseases | Value in Health | May 01, 2023 | Click here |
Alexion + Merck | DDEL-19. TREATMENT ADHERENCE OF SELUMETINIB AMONG PATIENTS DIAGNOSED WITH NEUROFIBROMATOSIS TYPE I AND PLEXIFORM NEUROFIBROMA IN THE UNITED STATES | Journal of Neuro-Oncology | Nov 01, 2022 | Click here |
Nestle | Clinical benefits of real food tube feeding formulas compared to standard tube feeding formulas in post-acute care pediatric patients | Journal of Pediatric Gastroenterology and Nutrition | Oct 12, 2022 | Click here |
Nestle | Health economic benefits of real food tube feeding formulas compared to standard tube feeding formulas in post-acute pediatric patients | Journal of Pediatric Gastroenterology and Nutrition | Oct 12, 2022 | Click here |
Nestle | Clinical benefits of real food tube feeding formulas compared to standard tube feeding formulas in post-acute care pediatric patients | Journal of Pediatric Gastroenterology and Nutrition | Oct 12, 2022 | Click here |
Janssen Pharmaceuticals | Persistence with macitentan versus other endothelin receptor antagonists in patients with pulmonary arterial hypertension: experience from a real-world data repository in the USA | European Heart Journal | Oct 03, 2022 | Click here |
Gossamer Bio | REAL-WORLD REFERRAL PATTERNS OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH) TO PULMONARY HYPERTENSION ASSOCIATION (PHA)-ACCREDITED COMPREHENSIVE CARE CENTERS IN THE STATE OF TEXAS (2019-2020) | Journal of Chest | Oct 01, 2022 | Click here |
University Medical Center | Length of Stay and Costs with Autologous Skin Cell Suspension Versus Split-Thickness Skin Grafts: Burn Care Data from US Centers | Advances in therapy | Sep 14, 2022 | Click here |
Nestle | Cost savings associated with commercial blenderized tube feeding formulas in post-acute care adult patients | Clinical Nutrition | Sep 03, 2022 | Click here |
Nestle | Health economic benefits of real food tube feeding formulas compared to standard tube feeding formulas in post-acute adult patients | Clinical Nutrition | Sep 03, 2022 | Click here |
AlloVir | Clinical and Economic Burden of Multiple Double-Stranded DNA Viral Infections after Allogeneic Hematopoietic Cell Transplantation | Transplantation and Cellular Therapy | Sep 01, 2022 | Click here |
AlloVir | Economic and clinical burden associated with respiratory viral infections after allogeneic hematopoietic cell transplant in the United States | Transplant Infectious Disease | May 22, 2022 | Click here |
Sarepta | Disease Progression Stages and Burden in Patients with Duchenne Muscular Dystrophy Using Administrative Claims Supplemented by Electronic Medical Records | Advances in therapy | Apr 23, 2022 | Click here |
Otsuka Pharmaceutical | RWD39 Early Experience with Aripiprazole Tablets with Sensor: Patient Costs from Real-World Data | Value in health | Apr 01, 2022 | Click here |
Nestle | Real-world evidence on clinical and health economic outcomes among pediatric patients in post-acute care receiving commercial blenderized tube feeding formulas | Journal of Parenteral and Enteral Nutrition | Mar 26, 2022 | Click here |
Daiichi Sankyo, Inc. | Relationship Between Initial Parenteral Iron Therapy Dosing and Treatment Effectiveness: A Real-World Retrospective Analysis | Journal of blood medicine | Mar 08, 2022 | Click here |
Janssen Scientific Affairs | Real-World Analysis of Weight Gain and Body Mass Index Increase Among Patients with HIV-1 Using Antiretroviral Regimen Containing Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, or Neither in the United States | Journal of health economics and outcomes research | Feb 22, 2022 | Click here |
Biohaven Pharma Inc. | Real-world assessment of the relationship between migraine-related disability and healthcare costs in the United States | Journal of Headache | Feb 14, 2022 | Click here |
Janssen Scientific Affairs | Body mass index increases and weight gain among people living with HIV-1 initiated on single-tablet darunavir/cobicistat/emtricitabine/tenofovir alafenamide or bictegravir/emtricitabine/tenofovir alafenamide in the United States | Current medical research and opinion | Dec 01, 2021 | Click here |
Alexion | Real-World Patient Characteristics, Treatment Patterns and Outcomes for Patients with Atypical Hemolytic Uremic Syndrome Who Have Switched from Eculizumab to Ravulizumab in the USA | Journal of Blood | Nov 23, 2021 | Click here |
Nestle | Real World Evidence Evaluation of the Characteristics of Chronic Pancreatitis and Type 2 Diabetes Patients Treated with Pancrelipase in the United States | The American Journal of Gastroenterology | Oct 01, 2021 | Click here |
Abbvie | Pediatric Acute Ischemic Stroke by Age-Group: A Systematic Review and Meta-Analysis of Published Studies and Hospitalization Records | Neuroepidemiology | Aug 17, 2021 | Click here |
The University of Texas at Austin | Utilization, adherence, and outcomes of 17-alpha hydroxyprogesterone caproate for recurrent spontaneous preterm birth prevention | Current medical research and opinion | Jun 07, 2021 | Click here |
Neurocrine | Limitations of Matched Control Groups Using Stabilization Criteria: A Case Study in CAH | Value in health | Jun 01, 2021 | Click here |
Neurocrine | Real-World Evidence of Clinical Outcomes in Patients with Assumed Classic Congenital Adrenal Hyperplasia in the United States | Journal of the Endocrine Society | May 03, 2021 | Click here |
Biohaven Pharma Inc. | MIDAS Disability Grades are Associated with Total Health Care and Pharmaceutical Costs – A US-Based Real World Longitudinal Analysis | Journal of Neurology | Apr 13, 2021 | Click here |
Nestle | Real-World Evidence of Treatment, Tolerance, Healthcare Utilization, and Costs Among Post Acute Care Adult Patients Receiving Enteral Peptide-Based Diets in the United States | Journal of Parenteral and Enteral Nutrition | Mar 18, 2021 | Click here |
Nestle | Tolerance, Healthcare Utilization and Cost of Enteral Peptide-Based Diets in Children in Post-Acute Care in the USA | Journal of Clinical Nutrition and Dietetics | Mar 10, 2021 | Click here |
Alexion | Economic and Clinical Burden of Virus-Associated Hemorrhagic Cystitis in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation in the United States | Transplantation and cellular therapy | Feb 26, 2021 | Click here |
Janssen Scientific Affairs | How well do clinical and demographic characteristics predict Patient Health Questionnaire-9 scores among patients with treatment-resistant major depressive disorder in a real-world setting? | Brain and Behavior | Jan 05, 2021 | Click here |
The University of Texas at Austin | Antihypertensive agent utilization patterns among patients with uncontrolled hypertension in the United States | Journal of clinical hypertension (Greenwich, Conn.) | Nov 01, 2020 | Click here |
Janssen Scientific Affairs | Treatment Patterns and Predictors of Adherence in HIV Patients Receiving Single- or Multiple-Tablet Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide | Patient Prefer Adherence | Nov 01, 2020 | Click here |
The University of Texas at Austin | Evaluation of progesterone (17-[alpha] hydroxyprogesterone caproate) utilization, adherence and outcomes in women with a high-risk pregnancy | THESIS | Sep 14, 2020 | Click here |
Abbot | Prognostic value of brain natriuretic peptide vs history of heart failure hospitalization in a large real-world population | Clinical Cardiology | Sep 01, 2020 | Click here |
Health Analytics LLC | Predicting Incident Treatment-Resistant Depression: A Model Designed for Health Systems of Care | Journal of managed care & specialty pharmacy | Aug 26, 2020 | Click here |
Sarepta | Real-world evidence of eteplirsen treatment effects on Duchenne muscular dystrophy related health outcomes using claims data in the United States | Neuromuscular Disorders. | Aug 01, 2020 | Click here |
Janssen Scientific Affairs | An assessment of weight change associated with the initiation of a protease or integrase strand transfer inhibitor in patients with human immunodeficiency virus | Current medical research and opinion | Aug 01, 2020 | Click here |
Daiichi Sankyo, Inc. | Effectiveness of Parenteral Iron Therapy in the Real-world Setting: A Retrospective Analysis | Journal of Clinical Hematology | Jul 20, 2020 | Click here |
Boehringer Ingelheim | Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA | Advances in therapy | Jul 01, 2020 | Click here |
Resmed Corp. | Epidemiology of Patients with Obstructive Sleep Apnea in the United States | American Journal of Respiratory and Critical Care Medicine | May 23, 2020 | Click here |
Drexel University | PMH29 EXAMINING HEALTHCARE UTILIZATION AND COSTS ASSOCIATED WITH NEGATIVE SYMPTOMS OF SCHIZOPHRENIA AND SUBSTANCE ABUSE DISORDER USING REAL WORLD EVIDENCE DATA | Value in health | Apr 01, 2020 | Click here |
– | PHYSICIAN REFERRAL PATTERNS FOR DIAGNOSTIC IMAGING MODALITY IN CAD PATIENTS | American College of Cardiology | Mar 25, 2020 | Click here |
GE Precision Healthcare LLC | IMPACT OF DIAGNOSTIC IMAGING MODALITY CHOICE ON LIKELIHOOD OF SUBSEQUENT INVASIVE CORONARY ANGIOGRAPHY IN CAD PATIENTS | Journal of the American College of Cardiology | Mar 01, 2020 | Click here |
Biohaven Pharma Inc. | Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management | Current medical research and opinion | Nov 01, 2019 | Click here |
The University of Texas at Austin | Antihypertensive Agent Utilization Among Uncontrolled Hypertension Patients with Diabetes and Chronic Kidney Disease in the United States | Journal of Managed Care & Specialty Pharmacy JMCP | Oct 01, 2019 | Click here |
Daiichi Sankyo, Inc. | Importance of Initial Complete Parenteral Iron Repletion on Hemoglobin Level Normalization and Health Care Resource Utilization: A Retrospective Analysis | Pharmacotherapy | Sep 11, 2019 | Click here |
Minerva Neurosciences | PMH25 REAL-WORLD EVIDENCE INVESTIGATION ON HEALTHCARE UTILIZATION AND COST AMONG NEGATIVE SYMPTOM PATIENTS AND NON-NEGATIVE SYMPTOM PATIENTS WITH SCHIZOPHRENIA IN THE US | Value in health | Apr 01, 2019 | Click here |
Daiichi Sankyo, Inc. | Importance of Complete Parenteral Iron Replacement on Hemoglobin Normalization: A Retrospective Analysis | Journal of Blood | Nov 29, 2018 | Click here |
Learn how Clarivate can help you advance innovation.